You are here

Advisory Committee on Vaccines (ACV)

Related information

8 January 2019

Role of the ACV

The ACV provides independent medical and scientific advice to the Minister for Health and the Therapeutic Goods Administration (TGA) on issues relating to the safety, quality and efficacy of vaccines supplied in Australia including issues relating to pre-market assessment, post-market monitoring and safe use in national immunisation programs.

The Committee is established under Regulation 39F of the Therapeutic Goods Regulations 1990 and the members are appointed by the Minister for Health.

The ACV was established in January 2017, following consolidation of previous functions of the Advisory Committee on the Safety of Vaccines (ACSOV) and the pre-market functions for vaccines of the Advisory Committee on Prescription Medicines (ACPM).

Membership comprises professionals with expertise in specific scientific, medical or clinical fields, or consumer health issues.



Professor Allen Cheng is an infectious diseases physician. His current appointments are as Director, Infection Prevention and Healthcare Epidemiology at Alfred Health, Adjunct Professor in the Department of Epidemiology and Preventative Medicine at Monash University, and as an Honorary Senior Research Fellow at the Menzies School of Health Research. Professor Cheng has diverse clinical experience in metropolitan and regional hospitals in Australia and internationally, and research interests in clinical infectious diseases, tropical medicine and influenza epidemiology. His PhD thesis was on the bacterial disease melioidosis. He has published over 200 peer-reviewed scientific publications. From 2009 to 2016 Professor Cheng was a member of the Advisory Committee on Prescription Medicines, and he is currently a member of the Australian Technical Advisory Group on Immunisation. Professor Cheng provides expertise in the field of infectious diseases in adults and children.


Ms Karen Booth is a registered nurse and accredited immuniser and currently works as a primary health care nurse consultant. She is President of the Australian Primary Health Care Nurses Association, and is a member of the National Immunisation Committee. Other committee and advisory roles have included participation in the Primary Health Care Advisory Group, a taskforce on pandemics, the development of nationally consistent immuniser accreditation programs, and on the Advisory Committee on the Safety of Vaccines throughout its period of operation. Ms Booth provides expertise in vaccine program implementation, the provision of immunisation treatment by an individual, and nursing.

Professor Jim Buttery is a paediatric infectious diseases physician and clinical researcher. He has been the Director of SAEFVIC, the Victorian immunisation safety service, since its formation in 2007. He is the Professor of Paediatric Epidemiology, Monash University; Head, Infection and Immunity, Monash Children's Hospital; and Head, Monash Immunisation, Monash Health. He is a member of the Scientific Board of the Brighton Collaboration and the President of the World Society of Paediatric Infectious Disease, and previously served on the Advisory Committee on the Safety of Vaccines. Professor Buttery provides expertise in infectious diseases in children, epidemiology, vaccine program implementation, and paediatrics.

Professor Michael Gold is a paediatric allergist and immunologist who holds conjoint positions in the discipline of Paediatrics at the University of Adelaide and is Head of Allergy and Immunology at the Women's and Children's Health Network. His extensive research and clinical interests include vaccine safety surveillance using data linkage, and febrile seizure following vaccination in children. He also researches in the prevention of food allergy. Professor Gold was a member of the World Health Organization Global Advisory Committee for Vaccine Safety from 2010-2016, and has served on the Advisory Committee on the Safety of Vaccines. Professor Gold provides expertise in the field of immunology and paediatrics.

Professor Paul Johnson is an infectious diseases physician in clinical practice and is the Deputy Director of the Infectious Diseases Department at Austin Health. He trained at the Austin Hospital Clinical School and Fairfield Infectious Diseases Hospital before moving to the Department of Microbiology at the Royal Children's Hospital where he commenced a long standing research program on the diagnosis, transmission and environmental reservoir of Mycobacterium ulcerans infections. Professor Johnson continues his clinical role at Austin Health and is conjointly Director, World Health Organisation Collaborating Centre for Mycobacterium ulcerans. Professor Johnson provides expertise in the field of infectious diseases in adults and children.

Dr Ling Li is a biostatistician and Senior Research Fellow in the Faculty of Medicine and Health Sciences at Macquarie University. She has a PhD in statistics from Macquarie University, and a Masters of Biostatistics from the University of Sydney. She has a strong record in study design, health data linkage, meta-analysis and statistical modelling. Her research interests include randomised controlled trials and observational studies, in both methodology development and application, and the quality use of pathology services. Dr Li provides expertise in the field of biostatistics.

Professor Kristine Macartney is the Acting Director of the National Centre for Immunisation Research & Surveillance, a paediatric infectious diseases specialist at The Children's Hospital at Westmead, and Professor in the Discipline of Paediatrics and Child Health, University of Sydney. Her doctoral thesis was on rotavirus infection and mucosal immunity. She was the senior technical editor of the Australian Immunisation Handbook (10th edition) and has research interests in viral vaccine preventable diseases, vaccine safety and policy-making. Professor Macartney served on the Advisory Committee on the Safety of Vaccines throughout its period of operation. Professor Macartney provides expertise in the fields of infectious diseases in children, virology, epidemiology and paediatrics.

Ms Louise Miller Frost is an experienced director and executive in the health and community services sectors. She has managed clinical services and dealt with clinical governance frameworks, risk management and ethical issues. Her qualifications include a Master of Public Health. She has worked as a consumer representative in the health sector on both national and state committees and currently sits on the SA Board of the Medical Board of Australia and the University of Adelaide's Advisory Committee for Masters Public Health and Masters Health Economics. Ms Miller Frost is the Chief Executive Officer / Executive Director of Catherine House Inc, a women's homelessness service. Ms Miller Frost provides expertise in consumer health issues.

Dr Nicholas Silberstein has extensive experience as a general practitioner in Melbourne, and his day-to-day work involves administration of vaccines to children and adults, both for the National Immunisation Program schedules as well as for travel. He has also undertaken placements as a medical coordinator for Médecins Sans Frontières and related organisations in developing countries. The topic of his Masters thesis was 'Rates of vaccination in two-year-old children in Western Australia', and Dr Silberstein is a member of the Australian Technical Advisory Group on Immunisation. Dr Silberstein provides expertise in the provision of immunisation treatment by an individual.

Dr Lauren Wilson obtained her PhD from the Australian National University. She has published on coronavirus and holds patents relating to anti-viral compounds. Dr Wilson has been the research leader in the Infectious Disease Research Laboratory at The Canberra Hospital, and has had various senior roles related to infectious diseases with other government agencies. She is currently undertaking a Secretary of Defence Research Fellowship. Dr Wilson is actively involved in mentoring and enjoys volunteering for scientists in schools to help inspire students in STEM (Science, Technology, Engineering and Mathematics). Dr Wilson provides expertise in virology, public health and infectious diseases.

2019 ACV proposed meeting dates

Meeting no. Meeting dates
12 6 February 2019
13 3 April 2019
14 5 June 2019
15 31 July 2019
16 2 October 2019
17 4 December 2019

Contact details for the ACV

Phone +61 2 6232 8665
Mobile +61 468 609 842
Fax +61 2 6203 1250
Postal Address Advisory Committee on Vaccines
Therapeutic Goods Administration
PO Box 100
Attn: Scheduling & Committee Support Section, MDP 122